Dr. Sandip Patel, M.D. is an Associate Professor at UCSD and a medical oncologist focused on early development of novel immunotherapy in solid tumors, in particular thoracic oncology immunotherapy trials. His lab focuses on computational immunopathology to derive spatial immune signatures that can inform novel immune target discovery.
He is co-leader for the Experimental Therapeutics (Phase 1) Program and Deputy Director for the Center for Precision Immunotherapy at UCSD. He is Director of the Clinical Trials Office at UCSD Moores Cancer Center and a member of the Cancer Immunotherapy, Experimental Therapeutics (Phase 1), and Thoracic Oncology Programs. Dr. Patel is the co-leader of the NRG Developmental Therapeutics Committee.
Dr. Patel earned his medical degree at Baylor College of Medicine, while performing research at MD Anderson Cancer Center. He completed a residency in Internal Medicine at UCLA Medical Center. He completed a fellowship in Medical Oncology and Hematology at Duke University Medical Center.
